In preparation for the 2005-06 flu season, CDC holds weekly planning calls with public health partners. AIM is represented on the calls by Chair Dan Hopfensperger (WI), Chair-elect Howard Backer (CA), and Epidemiology/Surveillance Committee Chair Kris Ehresmann (MN).

Executive Director Claire Hannan represents AIM on Partnership for Prevention’s immunization committee.

AIM participates in a coalition of national organizations supportive of the Section 317 immunization program led by the Association of State and Territorial Health Officials (ASTHO) and the American Academy of Pediatrics (AAP).

Executive Director Claire Hannan represents AIM on the Influenza Vaccine Summit, a national group of organizations with an interest in flu vaccination (manufacturers, distributors, providers, health plans, federal, state and local government, consumer groups, advocacy groups, etc.) convened by the American Medical Association and Centers for Disease Control and Prevention.

AIM Chair Dan Hopfensperger (WI) and AIM Epidemology/Surveillance Chair Kris Ehresmann (MN) represented AIM at the annual Influenza Vaccine Summit in May, 2005.

AIM Chair Dan Hopfensperger (WI) represents AIM on this national stakeholders group convened by the Institute of Medicine and The Keystone Center to coordinate input from the public on the goals and priorities of a potential pandemic influenza vaccination program.